Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
LCNB Corp
LCNB
$281M
| $561K | ﹤0.01% |
34,300
-13,400
| -28% | -$216K |
|
|
DLA
2702
DELISTED
Delta Apparel Inc.
DLA
| $559K | ﹤0.01% |
39,800
+19,400
| +95% | +$310K |
|
|
REXI
2703
DELISTED
RESOURCE AMERICA INC CL-A
REXI
| $559K | ﹤0.01% |
91,200
+32,000
| +54% | +$196K |
|
2704
Ezcorp Inc
EZPW
$1.78B
| $558K | ﹤0.01% |
111,727
-198,649
| -64% | -$1.17M |
|
|
PRAH
2705
DELISTED
PRA Health Sciences, Inc.
PRAH
| $552K | ﹤0.01% |
12,200
-37,700
| -76% | -$1.58M |
|
|
CTO
2706
CTO Realty Growth
CTO
$819M
| $548K | ﹤0.01% |
38,314
-15,841
| -29% | -$228K |
|
2707
Smith Micro Software
SMSI
$17M
| $547K | ﹤0.01% |
4,693
+258
| +6% | +$31.6K |
|
|
COB
2708
DELISTED
CommunityOne Bancorp
COB
| $547K | ﹤0.01% |
40,600
+19,300
| +91% | +$256K |
|
|
VIA
2709
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $545K | ﹤0.01% |
+10,520
| New | +$469K |
|
2710
Taoping
TAOP
$8.83M
| $544K | ﹤0.01% |
180
-10
| -5% | -$19.8K |
|
2711
Limoneira
LMNR
$251M
| $539K | ﹤0.01% |
36,100
+17,400
| +93% | +$281K |
|
|
HAYN
2712
DELISTED
Haynes International, Inc.
HAYN
| $539K | ﹤0.01% |
14,700
-15,300
| -51% | -$594K |
|
2713
Lincoln Educational Services
LINC
$945M
| $536K | ﹤0.01% |
269,200
-14,500
| -5% | -$23K |
|
|
AMBR
2714
DELISTED
Amber Road Inc
AMBR
| $535K | ﹤0.01% |
105,200
+52,292
| +99% | +$237K |
|
2715
FuelCell Energy
FCEL
$1.63B
| $533K | ﹤0.01% |
+299
| New | +$963K |
|
2716
V2X
VVX
$2.55B
| $530K | ﹤0.01% |
+25,364
| New | +$591K |
|
|
ACW
2717
DELISTED
Accuride Corp
ACW
| $530K | ﹤0.01% |
319,078
+111,878
| +54% | +$278K |
|
|
SYUT
2718
DELISTED
Synutra International, Inc.
SYUT
| $528K | ﹤0.01% |
112,100
-56,900
| -34% | -$292K |
|
|
SWSH
2719
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
| $524K | ﹤0.01% |
546,050
+64,600
| +13% | +$67.8K |
|
|
VYNT
2720
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $521K | ﹤0.01% |
1,053
+506
| +93% | +$366K |
|
|
EGLT
2721
DELISTED
Egalet Corporation
EGLT
| $521K | ﹤0.01% |
47,300
+15,500
| +49% | +$154K |
|
|
IMBI
2722
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $517K | ﹤0.01% |
29,056
-4,190
| -13% | -$99.4K |
|
|
IMGN
2723
DELISTED
Immunogen Inc
IMGN
| $516K | ﹤0.01% |
38,040
-355,400
| -90% | -$4.37M |
|
2724
Insight Enterprises
NSIT
$4.54B
| $515K | ﹤0.01% |
20,500
-63,473
| -76% | -$1.67M |
|
|
SMT
2725
DELISTED
SMART TECHNOLOGIES INC COM NEW
SMT
| $514K | ﹤0.01% |
176,892
+8,722
| +5% | +$35.4K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.